Human rotavirus vaccines: too early for the strain to tell

The Lancet

Volumn 371, Issue 9619, 2008, Pages 1144-1145

  Grimwood, Keith ^a   Kirkwood, Carl D ^b  

^a ROYAL CHILDREN'S HOSPITAL   (Australia)

^b MURDOCH CHILDREN'S RESEARCH INSTITUTE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ROTAVIRUS VACCINE;

ARTICLE; CLINICAL TRIAL; DIARRHEA; DISEASE SEVERITY; DRUG EFFICACY; DRUG MECHANISM; DRUG SAFETY; GASTROENTERITIS; HOSPITAL ADMISSION; HUMAN; HUMAN ROTAVIRUS; IMMUNIZATION; MORTALITY; PATHOGENESIS; PRIORITY JOURNAL; SOCIOECONOMICS; TREATMENT OUTCOME; VIRUS INFECTION; VIRUS STRAIN;

EID: 41549102977     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(08)60501-2     Document Type: Note

References (12)

1. World Health Organization. Rotavirus vaccines. Wkly Epidemiol Rec 82 (2007) 285-296
2. Vesikari T., Matson D., Dennehy P., et al., for the Rotavirus Efficacy and Safety Trial (REST) Study Team. Safety and efficacy of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine. N Engl J Med 354 (2006) 23-33
3. Ruiz-Palacios G., Perez-Schael I., Velazquez F., et al., for the Human Rotavirus Vaccine Study Group. Safety and efficacy of an attenuated vaccine against severe rotavirus gastroenteritis. N Engl J Med 354 (2006) 11-22
4. Glass R., Bresee J., Turcios R., Fischer T., Parashar U., and Steele A. Rotavirus vaccines: targeting the developing world. J Infect Dis 192 suppl 1 (2005) S160-S166
5. Linhares A., Velazquez F., Perez-Schael I., and the Human Rotavirus Vaccine Study Group. Efficacy and safety of an oral live attenuated human rotavirus vaccine against rotavirus gastroenteritis during the first 2 years of life in Latin American infants: a randomised, double-blind, placebo-controlled phase III study. Lancet 371 (2008) 1181-1189
6. Santos N., and Hoshino Y. Global distribution of rotavirus serotypes/genotypes and its implications for the development and implementation of an effective rotavirus vaccine. Rev Med Virol 15 (2005) 29-56
7. Velazquez F., Matson D., Calva J., et al. Rotavirus infection in infants as protection against subsequent infections. N Engl J Med 335 (1996) 1022-1028
8. Vesikari T., Karvonen A., Prymula R., et al. Efficacy of human rotavirus vaccine against rotavirus gastroenteritis during the first 2 years of life in European infants: randomised, double-blind controlled study. Lancet 370 (2007) 1757-1763
9. Bresee J., Hummelman E., Nelson E., and Glass R. Rotavirus in Asia: the value of surveillance for informing decisions about the introduction of new vaccines. J Infect Dis 192 suppl 1 (2005) S1-S5
10. Castello A., Arvay M., Glass R., and Gentsch J. Rotavirus strain surveillance in Latin America: a review of the last nine years. Pediatr Infect Dis J 23 suppl 10 (2004) S168-S172
11. Gurgel R., Cuevas L., Vieira S., et al. Predominance of rotavirus P[4]G2 in a vaccinated population, Brazil. Emerg Infect Dis 13 (2007) 1571-1573
12. Nakagomi T., Cuevas L., Gurgel R., et al. Apparent extinction of non-G2 rotavirus strains from circulation in Recife, Brazil, after the introduction of rotavirus vaccine. Arch Virol 153 (2008) 591-593